Operability and chemotherapy responsiveness in advanced low-grade serous ovarian cancer Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Friday, January 22, 2016

Operability and chemotherapy responsiveness in advanced low-grade serous ovarian cancer



abstract
  
Operability and chemotherapy responsiveness in advanced low-grade serous ovarian cancer. An analysis of the AGO Study Group metadatabase

Highlights

Primary low-grade serous ovarian cancer (LGSOC) is not as responsive to platinum-taxane-based chemotherapy as high-grade serous advanced ovarian cancer (HGSOC)
Surgical debulking showed a similar impact on outcome in primary LGSOC and HGSOC however LGSOC were associated with better prognosis

0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.